Patents by Inventor Qixing Ou

Qixing Ou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND RELATED METHODS FOR SUPPORTING COMPANION ANIMALS WITH GASTROINTESTINAL DISORDERS
    Publication number: 20230248788
    Abstract: Compositions are provided for providing support to companion animals affected by Inflammatory Bowel Disease (IBD) and/or Irritable Bowel Syndrome (IBS). In some embodiments, the composition comprises at least one isolated strain of wolf probiotic bacteria and at least one isolated strain of canine probiotic bacteria. In some embodiments, the composition further comprises at least one prebiotic. Also provided are related methods for preparing a composition and for treating IBS and/or IBD in a subject.
    Type: Application
    Filed: June 29, 2021
    Publication date: August 10, 2023
    Applicant: CANBIOCIN INC.
    Inventors: Qixing Ou, John F. Burlet, Petya Koleva
  • Probiotic bacteria isolated from wolves and related compositions and methods
    Patent number: 11666614
    Abstract: Isolates strains of gastrointestinal bacteria from wolves are provided for use as probiotics. In some embodiments, the isolated strains are for use as probiotics in canine subjects such as domestic dogs. In some embodiments, the isolated strains may be used to treat or prevent intestinal dysbiosis in the subject. Also provided are compositions comprising at least one isolated strain of wolf probiotic bacteria and related methods for making same.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: June 6, 2023
    Assignee: CanBiocin Inc.
    Inventors: Qixing Ou, John F. Burlet
  • PROBIOTIC BACTERIA ISOLATED FROM WOLVES AND RELATED COMPOSITIONS AND METHODS
    Publication number: 20210315949
    Abstract: Isolates strains of gastrointestinal bacteria from wolves are provided for use as probiotics. In some embodiments, the isolated strains are for use as probiotics in canine subjects such as domestic dogs. In some embodiments, the isolated strains may be used to treat or prevent intestinal dysbiosis in the subject. Also provided are compositions comprising at least one isolated strain of wolf probiotic bacteria and related methods for making same.
    Type: Application
    Filed: August 21, 2019
    Publication date: October 14, 2021
    Applicant: CanBiocin Inc.
    Inventors: Qixing Ou, John F. Burlet